Extending the Occupational Safety and Health Management System as a Knowledge Management System Through the Mixed-Reality Remote Audit

Auditing is one of the most important stages in evaluating the effectiveness of an Occupational Safety and Health Management System (OSHMS), which is also recognized as a Knowledge Management System (KMS). According to the International Labor Organization (ILO), the audit process is part of the evaluation element, where the auditor must evaluate the OSH performance. The traditional audit might not be able to be conducted due to the Covid-19 pandemic and the Movement Control Order (MCO) scenario, therefore the remote audit is being viewed as a viable solution to ensuring the audit process continues. The solution could also be utilized beyond the pandemic period as it may become one of the effective method for the audit process. The paper describes how the OSHMS can be remotely audited utilizing Mixed Reality (MR) applications in a design thinking manner. To test the approach, preliminary data was collected in an OSH office. The findings of this paper will aid stakeholders in the relevant context in making investment decisions for digitising their OSH audit process in order to create a future-ready ecosystem. © 2022, Springer Nature Switzerland AG.

The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It.

Coronavirus disease is caused by the SARS-CoV-2 virus. The virus first appeared in Wuhan (China) in December 2019 and has spread globally. Till now, it affected 269 million people with 5.3 million deaths in 224 countries and territories. With the emergence of variants like Omicron, the COVID-19 cases grew exponentially, with thousands of deaths. The general symptoms of COVID-19 include fever, sore throat, cough, lung infections, and, in severe cases, acute respiratory distress syndrome, sepsis, and death. SARS-CoV-2 predominantly affects the lung, but it can also affect other organs such as the brain, heart, and gastrointestinal system. It is observed that 75 % of hospitalized COVID-19 patients have at least one COVID-19 associated comorbidity. The most common reported comorbidities are hypertension, NDs, diabetes, cancer, endothelial dysfunction, and CVDs. Moreover, older and pre-existing polypharmacy patients have worsened COVID-19 associated complications. SARS-CoV-2 also results in the hypercoagulability issues like gangrene, stroke, pulmonary embolism, and other associated complications. This review aims to provide the latest information on the impact of the COVID-19 on pre-existing comorbidities such as CVDs, NDs, COPD, and other complications. This review will help us to understand the current scenario of COVID-19 and comorbidities; thus, it will play an important role in the management and decision-making efforts to tackle such complications.